People: POZEN Inc (POZN.O)

POZN.O on Nasdaq

9.09USD
24 Nov 2014
Price Change (% chg)

$0.23 (+2.57%)
Prev Close
$8.86
Open
$8.86
Day's High
$9.10
Day's Low
$8.86
Volume
195,693
Avg. Vol
292,021
52-wk High
$9.73
52-wk Low
$5.96

Search Stocks

Rudnick, Seth 

Brief Biography

Dr. Seth A. Rudnick, M.D., is an Independent Director of Pozen Inc., since July 25, 2011. He is Venture partner and previously general partner at Canaan Partners, a venture capital firm, since 1998. Formerly, Chief Executive Officer and Chairman of CytoTherapeutics Inc., a company developing stem cell-based therapies. Helped found and served as the Head of Research and Development for Ortho Biotech, a division of Johnson & Johnson focusing on cancer and chronic illnesses from 1991 to 1998. Serves of the Boards of the following privately held biotechnology companies: Chimerix, Inc., Liquidia Technologies, Inc., ORTHOCON, Inc., Spine Wave, Inc. and VaxInnate, Inc. Currently a Clinical Adjunct Professor of Medicine at University of North Carolina, Chapel Hill.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Plachetka

2,726,560

William Hodges

626,065

Gilda Thomas

603,511

Dennis McNamara

--

John Barnhardt

623,095

John Fort

652,460
As Of 30 Dec 2013
Search Stocks